Coronavirus: How can we help?

OniX supports the research enterprise by providing an one-stop research knowledge hub that includes non-confidential technology summaries of funded and unfunded grants applications/ideas from government and private foundations; technology transfer assets from universities, government and others; startups, incubators and biotechnology companies non-confidential technology summaries. In addition, we provide access to journal publications, patents, clinical trials and news.

OniX can support the ongoing efforts to accelerate vaccines, diagnostics and treatments for the coronavirus, as well as, to stay up-to-the minute of any news and discoveries via OniX e-mail alerts.

A quick search of OniX shows hundreds of ideas, publications, patents, clinical trials and news.

For example:

Ideas/Abstract titles include:

• Risk of future coronavirus (CoV) emergence

• Coronavirus: Stages in the virus life cycle are promising targets for therapeutic intervention

• Development Of A Plant-Derived Virus-Like Particle Vaccine

• Coronavirus RNA Replication

• Role Of TLR4 In Coronavirus Infection

• Research on development of diagnostic tests for the novel coronavirus disease (COVID-19)

• Development of COVID-19 vaccine

Publications include:

• Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).

• Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.

• Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.

• Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.

• The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.

Clinical Trials include:

• Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)

• A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19)

• Efficacy and safety of chloroquine phosphate inhalation combined with standard therapy in the treatment of novel coronavirus pneumonia (COVID-19)

• A single-center, open-label and single arm trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment of novel coronavirus pneumonia (COVID-19) patient

• Clinical study for combination of anti-viral drugs and type I interferon and inflammation inhibitor TFF2 in the treatment of novel coronavirus pneumonia (COVID-19)

Patents include:

• Novel Coronavirus Inhibitors

• Anti-Coronavirus Drug

• Methods and Compositions for Coronavirus Diagnostic and Therapeutics

• Cordycepin showing antiviral effects against coronavirus activity

• Ribozyme to cleave coronavirus gene

Please reach out to find out how we can help at ask@onixhub.com